Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Danxue Huang
Observed name:
Huang, Danxue
Institution:
Liaoning Cancer Hospital & Institute
Observed institutions:
Shenyang Pharmaceutical University,
China Medical University,
Liaoning Cancer Hospital & Institute,
China Medical University
ORCID:
0009-0000-3855-922X
Observed ORCID:
0009-0000-3855-922X
OpenAlex ID:
A5080057262
An integrated plasma and urinary metabonomic study using UHPLC–MS: Intervention effects of Epimedium koreanum on ‘Kidney-Yang Deficiency syndrome’ rats
2012
·
Danxue Huang
, Jie Yang
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
53
LC–MS/MS determination and pharmacokinetic study of four lignan components in rat plasma after oral administration of Acanthopanax sessiliflorus extract
2012
·
Yang Song
, Ying Deng
, et al.
·
Journal of Ethnopharmacology
·
29
Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trials
2023
·
Danxue Huang
, Liyuan Ke
, et al.
·
BMC Cancer
·
26
PDF
The predictive value of tumor mutation burden on survival of gastric cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
2023
·
Liyuan Ke
, Su Li
, et al.
·
International Immunopharmacology
·
23
The predictive role of tertiary lymphoid structures in the prognosis and response to immunotherapy of lung cancer patients: a systematic review and meta-analysis
2025
·
Xin Liu
, Wu Lv
, et al.
·
BMC Cancer
·
22
PDF
Efficacy and safety of immune checkpoint inhibitors for advanced or recurrent endometrial cancer: a systematic review and network meta-analysis
2024
·
Danxue Huang
, Su Li
, et al.
·
BMC Cancer
·
16
PDF
Perioperative immune checkpoint inhibitors combined with chemotherapy versus chemotherapy for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis of randomized controlled trials
2024
·
Danxue Huang
, Feilong Sun
, et al.
·
International Immunopharmacology
·
13
Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials
2024
·
Danxue Huang
, Liyuan Ke
, et al.
·
BMC Women s Health
·
13
PDF
Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
2025
·
Zhe Wang
, Danxue Huang
, et al.
·
Frontiers in Immunology
·
12
PDF
Efficacy and safety of first- versus second-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis
2024
·
Liyuan Ke
, Su Li
, et al.
·
Frontiers in Pharmacology
·
8
PDF
Efficacy and safety of antibody-drug conjugates for HER2-expressing advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis
2025
·
Danxue Huang
, Feilong Sun
, et al.
·
Frontiers in Pharmacology
·
1
PDF
Efficacy and safety of first- versus second-generation fibroblast growth factor receptor (FGFR) inhibitors in advanced or metastatic urothelial carcinoma with FGFR alterations: a systematic review and meta-analysis
2026
·
Zhe Wang
, Bo Shao
, et al.
·
Frontiers in Pharmacology
PDF
Treatment-Related Adverse Events of Subcutaneous Monoclonal Antibodies in Cancer Patients: A Systemic Review and Meta-Analysis
2024
·
Baowanze Zhang
, Hongxia Cui
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
17
Citation count:
216
H-index:
9
I10-index:
9
Year
Topic
Type